Related Experiment Video
Updated: Nov 9, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Severe Preeclampsia is Associated with Functional and Structural Cardiac Alterations: A Case-control Study.
Derya Kilic1, Tolga Guler1, Cihan Ilyas Sevgican2
1Department of Obstetrics and Gynecology, Pamukkale University, Denizli, Turkey.
Severe preeclampsia (PE) is linked to cardiac structural changes, including increased left ventricular mass and wall thickness. Early-onset PE shows more significant diastolic dysfunction and left ventricular remodeling.
Area of Science:
- Cardiology
- Obstetrics
- Perinatology
Background:
- Severe preeclampsia (PE) poses significant risks to maternal and fetal health.
- Cardiac function and structure can be affected by hypertensive disorders of pregnancy.
Purpose of the Study:
- To compare electrocardiographic and echocardiographic findings in severe preeclampsia versus uncomplicated pregnancies.
- To identify cardiac alterations associated with severe preeclampsia.
Main Methods:
- A prospective, case-controlled study.
- Inclusion of 21 pregnant women with severe PE and 24 matched healthy pregnant controls.
- All participants underwent electrocardiographic and echocardiographic assessments.
Main Results:
- Patients with severe PE exhibited shorter QRS intervals and longer PR intervals compared to controls.
- Significant increases in left ventricular end-systolic diameter, posterior wall thickness, left ventricular mass, and relative wall thickness were observed in the PE group.
- Early-onset severe PE was associated with larger left ventricular end-diastolic diameter and volume.
Conclusions:
- Detected structural cardiac changes in severe PE suggest a chronic process.
- Diastolic dysfunction and left ventricular remodeling are more pronounced in severe early-onset PE.
- These findings highlight the cardiac impact of severe preeclampsia.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mitral Valve Prolapse III: Nursing Management
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy

